|
🐜
|
Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype.
12 auth.
C. Bloomfield,
David S. Lawrence,
J. Byrd,
A. Carroll,
M. Pettenati,
R. Tantravahi,
...
S. Patil,
F. Davey,
D. Berg,
C. Schiffer,
D. Arthur,
R. J. Mayer
|
9 |
1998 |
9
🐜
|
|
🐜
|
Rearrangement of ALL1 (MLL) in acute myeloid leukemia with normal cytogenetics.
19 auth.
M. Caligiuri,
M. Strout,
David S. Lawrence,
D. Arthur,
M. Baer,
F. Yu,
S. Knuutila,
K. Mrózek,
A. R. Oberkircher,
G. Marcucci,
...
A. Chapelle,
E. Elonen,
A. Block,
P. Rao,
G. Herzig,
B. Powell,
T. Ruutu,
C. Schiffer,
C. Bloomfield
|
7 |
1998 |
7
🐜
|
|
🐜
|
Expression of the neural cell adhesion molecule CD56 is associated with short remission duration and survival in acute myeloid leukemia with t(8;21)(q22;q22).
8 auth.
M. Baer,
Carleton C. Stewart,
David S. Lawrence,
D. Arthur,
J. Byrd,
F. Davey,
...
C. Schiffer,
C. Bloomfield
|
7 |
1997 |
7
🐜
|
|
🐜
|
Extramedullary leukemia adversely affects hematologic complete remission rate and overall survival in patients with t(8;21)(q22;q22): results from Cancer and Leukemia Group B 8461.
15 auth.
J. Byrd,
R. Weiss,
D. Arthur,
David S. Lawrence,
M. Baer,
F. Davey,
E. S. Trikha,
A. Carroll,
R. Tantravahi,
M. Qumsiyeh,
...
S. Patil,
J. Moore,
R. J. Mayer,
C. Schiffer,
C. Bloomfield
|
7 |
1997 |
7
🐜
|
|
🐜
|
Single-Dose Liposomal Amphotericin B Treatment for Cryptococcal Meningitis
42 auth.
J. Jarvis,
David S. Lawrence,
D. Meya,
E. Kagimu,
J. Kasibante,
Edward Mpoza,
M. Rutakingirwa,
K. Ssebambulidde,
L. Tugume,
Joshua Rhein,
D. Boulware,
H. Mwandumba,
Melanie Moyo,
H. Mzinganjira,
C. Kanyama,
...
M. Hosseinipour,
Chimwemwe Chawinga,
G. Meintjes,
C. Schutz,
K. Comins,
Achita Singh,
C. Muzoora,
Samuel Jjunju,
E. Nuwagira,
M. Mosepele,
T. Leeme,
Keatlaretse Siamisang,
C. Ndhlovu,
A. Hlupeni,
Constantine Mutata,
E. van Widenfelt,
Tao Chen,
Duolao Wang,
W. Hope,
Timothée Boyer-Chammard,
A. Loyse,
S. Molloy,
N. Youssouf,
O. Lortholary,
D. Lalloo,
S. Jaffar,
T. Harrison
|
7 |
2022 |
7
🐜
|
|
🐜
|
Short-course High-dose Liposomal Amphotericin B for Human Immunodeficiency Virus–associated Cryptococcal Meningitis: A Phase 2 Randomized Controlled Trial
19 auth.
J. Jarvis,
T. Leeme,
M. Molefi,
Awilly A. Chofle,
Gabriella Bidwell,
K. Tsholo,
N. Tlhako,
N. Mawoko,
Raju K K Patel,
M. Tenforde,
...
C. Muthoga,
G. Bisson,
Jeremiah Kidola,
J. Changalucha,
David S. Lawrence,
S. Jaffar,
W. Hope,
S. Molloy,
T. Harrison
|
6 |
2018 |
6
🐜
|
|
🐢
|
Neurosyphilis in patients with HIV
E. Hobbs,
J. Vera,
M. Marks,
A. Barritt,
B. Ridha,
David S. Lawrence
|
5 |
2018 |
5
🐢
|
|
🐜
|
Mortality from HIV‐associated meningitis in sub‐Saharan Africa: a systematic review and meta‐analysis
7 auth.
M. Tenforde,
A. Gertz,
David S. Lawrence,
Nicola K Wills,
B. Guthrie,
C. Farquhar,
...
J. Jarvis
|
5 |
2020 |
5
🐜
|
|
🐬
|
Diagnostic performance of PCR assays for the diagnosis of neurosyphilis: a systematic review
M. Marks,
David S. Lawrence,
C. Kositz,
D. Mabey
|
5 |
2018 |
5
🐬
|
|
🦁
|
AMBIsome Therapy Induction OptimisatioN (AMBITION): High Dose AmBisome for Cryptococcal Meningitis Induction Therapy in sub-Saharan Africa: Study Protocol for a Phase 3 Randomised Controlled Non-Inferiority Trial
29 auth.
David S. Lawrence,
N. Youssouf,
S. Molloy,
A. Alanio,
Melanie Alufandika,
D. Boulware,
Timothée Boyer-Chammard,
Tao Chen,
F. Dromer,
A. Hlupeni,
W. Hope,
M. Hosseinipour,
C. Kanyama,
O. Lortholary,
A. Loyse,
...
D. Meya,
M. Mosepele,
C. Muzoora,
H. Mwandumba,
C. Ndhlovu,
L. Niessen,
C. Schutz,
K. Stott,
Duolao Wang,
D. Lalloo,
G. Meintjes,
S. Jaffar,
T. Harrison,
J. Jarvis
|
5 |
2018 |
5
🦁
|
